trending Market Intelligence /marketintelligence/en/news-insights/trending/dg9io6wd3imqtrblegxgia2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Eleven Biotherapeutics changes name to Sesen Bio

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


Eleven Biotherapeutics changes name to Sesen Bio

Eleven Biotherapeutics Inc. is changing its name to Sesen Bio Inc.

The company's shares will start trading under the new name and Nasdaq ticker symbol SESN, effective May 17.

Eleven Biotherapeutics is a biologic oncology company that focuses on the design and development of targeted protein therapeutics addressing areas of unmet medical needs in cancer.